Effect of l-asparaginase therapy for acute lymphoblastic leukemia on plasma vitamin K-dependent coagulation factors and inhibitors
- 1 May 1986
- journal article
- research article
- Published by Elsevier in The Journal of Pediatrics
- Vol. 108 (5) , 698-701
- https://doi.org/10.1016/s0022-3476(86)81044-7
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- DECREASE IN PROTEIN C IN L-ASPARAGINASE-TREATED PATIENTSBritish Journal of Haematology, 1985
- Recurrent Venous Thromboembolism in Patients with a Partial Deficiency of Protein SNew England Journal of Medicine, 1984
- Plasma protein S deficiency in familial thrombotic diseaseBlood, 1984
- The effect of l-asparaginase on antithrombin, plasminogen, and plasma coagulation during therapy for acute lymphoblastic leukemiaThe Journal of Pediatrics, 1982
- A syndrome of thrombosis and hemorrhage complicating l-asparaginase therapy for childhood acute lymphoblastic leukemiaThe Journal of Pediatrics, 1982
- Deficiency of protein C in congenital thrombotic disease.Journal of Clinical Investigation, 1981
- L-ASPARAGINASE, ANTITHROMBIN III, AND THROMBOSISThe Lancet, 1980
- The effect of L‐asparaginase on plasma coagulation factors in acute lymphoblastic leukemiaCancer, 1977
- L-Asparaginase: Clinical, Biochemical, Pharmacological, and Immunological StudiesAnnals of Internal Medicine, 1971
- Blood Coagulation Changes under L-Asparaginase TherapyPublished by Springer Nature ,1970